Great people think alike, lol. Your estimates and mine are quite similar as noted in my previous post. We'll see. A lot depends on what's happening at the corporate level though.
Number 4 and 5 are conservative, we will be moving multiple myeloma into human testing between July and december IMO , which we will be asking for orphan drug approval. Check out what gwph stock did when they were going through the process.